Corporate Banner
Satellite Banner
Food & Beverage Analysis
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Nestlé Health Science Develops Brain Health Portfolio With New Acquisition

Published: Friday, July 20, 2012
Last Updated: Thursday, July 19, 2012
Bookmark and Share
Nestlé Health Science acquires stake in US firm Accera to support trials and rollout of Axona for Alzheimer’s Disease.

Nestlé Health Science has acquired a stake in Accera, a privately-held US-based company, which specializes in the research, development and commercialization of medical foods for neurodegenerative disorders like Alzheimer’s which affects more than 30 million people worldwide.

Accera’s key brand Axona, a medical food which is already on the market in the USA, is intended for the clinical dietary management of mild to moderate Alzheimer’s disease (AD).

“Our stake in Accera is a strategic step forward in building up our brain health portfolio,” said Nestlé Health Science President and CEO Luis Cantarell.

“Axona is an innovative medical food with a well understood mode of action and offers the potential for personalized nutrition for AD patients,” he added.

Axona’s mechanism of action
Alzheimer’s disease (AD) is the most common adult form of dementia and results in chronic and irreversible cognitive impairment. As AD progresses, the brain becomes less able to use glucose for the energy it needs.

Accera’s ongoing clinical trials show that Axona is metabolized by the liver to produce ketone bodies, which are naturally occurring compounds the brain can use as an alternative energy source.

This results in improved memory and cognitive function in mild to moderate AD patients.

Axona is already on the market in the US, prescribed to up to 30,000 people with mild to moderate Alzheimer’s.

Clinical Expertise
Nestlé has many years of experience researching the relationship between nutrition and cognitive function. It is critical that new solutions are found to manage cognitive decline, a major challenge in the public health arena, and Nestlé Health Science is well placed to contribute to this effort.

The investment in Accera by Nestlé Health Science will allow the collection of more extensive clinical data to support existing research into Axona.

“Nestlé Health Science’s investment will enable us to expand our clinical development programme and strengthen our commercial capabilities in the US,” said Accera’s President and CEO Holger Kunze.

“Longer term, it will also give us the opportunity to enlarge the geographic footprint of Axona.”

Personalized Nutrition
Nestlé Health Science, a fully owned subsidiary of Nestlé, aims to pioneer a new industry between the traditional nutrition and pharmaceutical industries through the development of science-based personalized nutritional solutions and shaping a new approach to disease prevention and management.

The decision to take a stake in Accera fits the strategic roadmap set out when Nestlé Health Science was created at the start of 2011.

Building on its core HealthCare Nutrition business, Nestlé Health Science has ambitions to address chronic conditions in the area of Gastrointestinal Health, Metabolic Health and Brain Health.

Recent Acquisitions
Nestlé Health Science has made several acquisitions and investments, which fit its strategic ambitions:
• Vitaflo, a provider of clinical nutritional solutions for infants, children and adults with genetic disorders that affect how food is processed by the body.
• CM&D Pharma Ltd., a company that specializes in the development of products for patients with chronic conditions like chronic kidney disease.
• Prometheus Laboratories, a US firm specializing in diagnostics and licensed speciality pharmaceuticals in GI and oncology.
• Vital Foods, a minority stake in a New Zealand based company that specializes in the development of kiwifruit-based solutions for gastrointestinal conditions.

Supporting Accera
Nestlé’s venture capital fund Inventages has been supporting Accera since 2004 and has a seat on its board. As part of the transaction Nestlé Health Science will also take a seat on the board.

The terms of the transaction are not being disclosed.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Health Risks of Saturated Fats Aggravated by Immune Response
Research shows that the presence of saturated fats resulted in monocytes migrating into the tissues of vital organs.
Decrease in Foodborne Outbreaks in Denmark
Almost every other registered salmonella infection in Denmark in 2014 was brought back by Danes travelling overseas.
How Safe Is Your Ground Beef?
If you don’t know how the ground beef you eat was raised, you may be putting yourself at higher risk of illness from dangerous bacteria. You okay with that?
Sweeteners Detected in Human Breast Milk
New data show that multiple types of NNS can be passed to nursing infants.
Food Science Team Finds Key to Tasty, Salt-Reduced Bread
Three food science researchers at the University of Alberta have discovered how to reduce salt in bread by half without compromising its taste or texture.
Yorkshire Scientists Could Hold Key to Preventing Future Horsemeat Scandals
Incidents like the horse meat scandal, which caused extensive damage to the UK’s farming and retail industry, could be consigned to the past thanks to revolutionary technology developed in the UK.
Detecting Hidden Ingredients
Researchers from China have used mass spectrometry to reveal the use of undeclared substances in dietary supplements.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
How To Keep Your Rice Arsenic-Free
Researchers at Queen’s University Belfast have made a breakthrough in discovering how to lower worrying levels of arsenic in rice that is eaten all over the world.
Pesticide Found in 70 Percent of Massachusetts’ Honey Samples
New Harvard University study says that the pesticide commonly found in honey samples is implicated in Colony Collapse Disorder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!